ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $52.3M

      Shares

      4.02M

      % of Portfolio

      0.38%

      Average Buy Price

      $23.2

      Avg closing price
      Price range

      21 Cathie Wood Adaptive Biotechnologies Trades

      Cathie Wood's position in Adaptive Biotechnologies is currently worth $52.3M. That's 0.38% of their equity portfolio (44th largest holding). The investor owns 2.61% of the outstanding Adaptive Biotechnologies stock. The first Adaptive Biotechnologies trade was made in Q2 2020. Since then Cathie Wood bought shares fifteen more times and sold shares on five occasions. The investor's estimated purchase price is $93.1M, resulting in a loss of 44%.

      Avg closing price
      Price range
      Sold 48.1% shares (-3.72M shares) Q2 2025
      Avg closing price $9.07
      Price range $6.83 - $12.16
      Sold 17.9% shares (-1.69M shares) Q1 2025
      Avg closing price $7.67
      Price range $6.07 - $8.66
      Sold 18.8% shares (-2.18M shares) Q4 2024
      Avg closing price $5.55
      Price range $4.37 - $6.78
      Increased shares by 1.7% (+189k shares) Q3 2024
      Avg closing price $4.35
      Price range $3.37 - $5.12
      Increased shares by 8.1% (+851k shares) Q2 2024
      Avg closing price $3.17
      Price range $2.33 - $3.96
      Sold 17.5% shares (-2.25M shares) Q1 2024
      Avg closing price $3.87
      Price range $2.88 - $4.80
      Increased shares by 11.3% (+1.3M shares) Q4 2023
      Avg closing price $4.56
      Price range $3.46 - $5.33
      Increased shares by 10.1% (+1.06M shares) Q3 2023
      Avg closing price $6.61
      Price range $5.07 - $8.44
      Increased shares by 13.6% (+1.25M shares) Q2 2023
      Avg closing price $7.44
      Price range $6.19 - $8.78
      Increased shares by 0.0% (+3.88k shares) Q1 2023
      Avg closing price $8.82
      Price range $7.80 - $10.11
      Sold 1.4% shares (-135k shares) Q4 2022
      Avg closing price $7.78
      Price range $6.26 - $9.34
      Increased shares by 6.4% (+564k shares) Q3 2022
      Avg closing price $9.42
      Price range $6.50 - $12.67
      Increased shares by 13.8% (+1.06M shares) Q2 2022
      Avg closing price $8.79
      Price range $6.40 - $14.73
      Increased shares by 35.3% (+2.01M shares) Q1 2022
      Avg closing price $15.72
      Price range $10.12 - $28.90
      Increased shares by 17.3% (+841k shares) Q4 2021
      Avg closing price $30.65
      Price range $25.17 - $36.85
      Increased shares by 11.2% (+489k shares) Q3 2021
      Avg closing price $36.17
      Price range $30.02 - $39.87
      Increased shares by 25.7% (+893k shares) Q2 2021
      Avg closing price $38.88
      Price range $32.22 - $44.59
      Increased shares by 124.7% (+1.93M shares) Q1 2021
      Avg closing price $54.13
      Price range $37.26 - $67.74
      Increased shares by 74.7% (+661k shares) Q4 2020
      Avg closing price $51.56
      Price range $45.01 - $65.47
      Increased shares by 186.2% (+576k shares) Q3 2020
      Avg closing price $42.03
      Price range $35.79 - $48.81

      News about Adaptive Biotechnologies Corp and Cathie Wood

      Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

      Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

      Cathie Wood bought shares of Shopify, Intellia, and Adaptive Biotechnologies on Tuesday. Shopify has surrendered 26% of its value over the past two weeks sin...

      fool.com fool.com, over 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×